187 related articles for article (PubMed ID: 37925349)
1. Clinical Application of Digital and Computational Pathology in Renal Cell Carcinoma: A Systematic Review.
Khene ZE; Kammerer-Jacquet SF; Bigot P; Rabilloud N; Albiges L; Margulis V; De Crevoisier R; Acosta O; Rioux-Leclercq N; Lotan Y; Rouprêt M; Bensalah K
Eur Urol Oncol; 2024 Jun; 7(3):401-411. PubMed ID: 37925349
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature.
Campi R; Stewart GD; Staehler M; Dabestani S; Kuczyk MA; Shuch BM; Finelli A; Bex A; Ljungberg B; Capitanio U
Eur Urol Oncol; 2021 Feb; 4(1):22-41. PubMed ID: 33408053
[TBL] [Abstract][Full Text] [Related]
4. Estimating Postoperative Renal Function After Surgery for Nonmetastatic Renal Masses: A Systematic Review of Available Prediction Models.
Pecoraro A; Campi R; Bertolo R; Mir MC; Marchioni M; Serni S; Joniau S; Van Poppel H; Albersen M; Roussel E
Eur Urol Oncol; 2023 Apr; 6(2):137-147. PubMed ID: 36631353
[TBL] [Abstract][Full Text] [Related]
5. Machine learning in oral squamous cell carcinoma: Current status, clinical concerns and prospects for future-A systematic review.
Alabi RO; Youssef O; Pirinen M; Elmusrati M; Mäkitie AA; Leivo I; Almangush A
Artif Intell Med; 2021 May; 115():102060. PubMed ID: 34001326
[TBL] [Abstract][Full Text] [Related]
6. Pathomics in urology.
Schuettfort VM; Pradere B; Rink M; Comperat E; Shariat SF
Curr Opin Urol; 2020 Nov; 30(6):823-831. PubMed ID: 32881725
[TBL] [Abstract][Full Text] [Related]
7. Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma.
Khene ZE; Bigot P; Doumerc N; Ouzaid I; Boissier R; Nouhaud FX; Albiges L; Bernhard JC; Ingels A; Borchiellini D; Kammerer-Jacquet S; Rioux-Leclercq N; Roupret M; Acosta O; De Crevoisier R; Bensalah K;
Eur Urol Oncol; 2023 Jun; 6(3):323-330. PubMed ID: 35987730
[TBL] [Abstract][Full Text] [Related]
8. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity.
Shuch B; Amin A; Armstrong AJ; Eble JN; Ficarra V; Lopez-Beltran A; Martignoni G; Rini BI; Kutikov A
Eur Urol; 2015 Jan; 67(1):85-97. PubMed ID: 24857407
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence in Pathomics and Genomics of Renal Cell Carcinoma.
Knudsen JE; Rich JM; Ma R
Urol Clin North Am; 2024 Feb; 51(1):47-62. PubMed ID: 37945102
[TBL] [Abstract][Full Text] [Related]
10. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review.
Lommen K; Vaes N; Aarts MJ; van Roermund JG; Schouten LJ; Oosterwijk E; Melotte V; Tjan-Heijnen VC; van Engeland M; Smits KM
Eur Urol Oncol; 2021 Apr; 4(2):215-226. PubMed ID: 31402218
[TBL] [Abstract][Full Text] [Related]
12. Revolutionizing Digital Pathology With the Power of Generative Artificial Intelligence and Foundation Models.
Waqas A; Bui MM; Glassy EF; El Naqa I; Borkowski P; Borkowski AA; Rasool G
Lab Invest; 2023 Nov; 103(11):100255. PubMed ID: 37757969
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence and algorithmic computational pathology: an introduction with renal allograft examples.
Farris AB; Vizcarra J; Amgad M; Cooper LAD; Gutman D; Hogan J
Histopathology; 2021 May; 78(6):791-804. PubMed ID: 33211332
[TBL] [Abstract][Full Text] [Related]
14. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence as the next step towards precision pathology.
Acs B; Rantalainen M; Hartman J
J Intern Med; 2020 Jul; 288(1):62-81. PubMed ID: 32128929
[TBL] [Abstract][Full Text] [Related]
16. Development of a Histopathology Informatics Pipeline for Classification and Prediction of Clinical Outcomes in Subtypes of Renal Cell Carcinoma.
Marostica E; Barber R; Denize T; Kohane IS; Signoretti S; Golden JA; Yu KH
Clin Cancer Res; 2021 May; 27(10):2868-2878. PubMed ID: 33722896
[TBL] [Abstract][Full Text] [Related]
17. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Ljungberg B; Albiges L; Abu-Ghanem Y; Bensalah K; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Kuusk T; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Tahbaz R; Volpe A; Bex A
Eur Urol; 2019 May; 75(5):799-810. PubMed ID: 30803729
[TBL] [Abstract][Full Text] [Related]
18. Machine learning models for diabetes management in acute care using electronic medical records: A systematic review.
Kamel Rahimi A; Canfell OJ; Chan W; Sly B; Pole JD; Sullivan C; Shrapnel S
Int J Med Inform; 2022 Apr; 162():104758. PubMed ID: 35398812
[TBL] [Abstract][Full Text] [Related]
19. Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma.
Chen S; Jiang L; Gao F; Zhang E; Wang T; Zhang N; Wang X; Zheng J
Br J Cancer; 2022 Mar; 126(5):771-777. PubMed ID: 34824449
[TBL] [Abstract][Full Text] [Related]
20. Deep computational pathology in breast cancer.
Duggento A; Conti A; Mauriello A; Guerrisi M; Toschi N
Semin Cancer Biol; 2021 Jul; 72():226-237. PubMed ID: 32818626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
